![]() Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. | ![]() TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. | ![]() Amolyt Pharma Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer. | |
Founding Date | Founding Date 2001 | Founding Date 2006 | Founding Date 2015 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Norcross, US HQ | Locations San Diego, US HQ | Locations Écully, FR HQ Cambridge, US |
Employees | Employees 717% increase | Employees 268% increase | Employees 373% decrease |
Valuation ($) | Valuation ($) 155.1 m | Valuation ($) 279.4 k | Valuation ($) N/A |
Financial | |||
Net income | Net income ($30.8m) (FY, 2025) | Net income ($3.6m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 41m | Total funding raised $ 93.1m |

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View company
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
View company